Alterations in TP53 were identified in 72 of 81 samples (89%), which was a similar rate to that observed in other studies of basal-like breast cancer or TNBC, and The Cancer Genome Atlas dataset (~85%)[11]. Here, TP53 is linked to breast cancer.